Akadeum Wins Technology Disruptor of the Year for Alerion™ Microbubble Cell Separation System

Published on Jan 27, 2025 Share

Akadeum Life Sciences was honored with the Technology Disruptor of the Year Award at Advanced Therapies Week 2025 for the innovative Alerion™ Microbubble Cell Separation System and microbubble technology. This award celebrates and recognizes technologies that significantly advance the field of cell and gene therapy.

The Alerion represents a paradigm shift in cell separation technology. By utilizing microbubbles, this system improves the efficiency and scalability of therapeutic cell production by enabling separation of up to a hundred billion cells quickly and gently, which is crucial for the advancement of autologous and allogeneic cell therapy manufacturing. Untouched cells and less handling of cells contribute to significantly improved cell health and viability, healthier cells are better engineered cells, and better engineered cells enable more effective therapies.

Technology Disruptor of the Year: Advancing Cell Therapy With Alerion™

Receiving the Technology Disruptor of the Year Award highlights the system’s capability to streamline cell processing workflows, reduce costs, and enhance the accessibility of advanced therapies to patients by reducing manufacturing failure risks (via healthier cells) and the potential to increase the number of doses produced per manufacturing run (via more viable cells).

This recognition and award category underscores the importance of innovative technologies in overcoming current challenges in cell therapy manufacturing to move the field forward. As the industry strives to deliver effective treatments to patients, innovations like Akadeum’s microbubble technology are critical to achieving that goal. The award acknowledges Akadeum’s dedication to enhancing human health, as a pioneer in buoyancy-based separation and with a team of innovators on a mission to deliver game-changing products.

About Advanced Therapies Week

Advanced Therapies Week, held from January 20–23, 2025, in Dallas, Texas, is a premier event for the cell and gene therapy community. Serving as a dynamic forum for knowledge sharing, relationship building, and deal-making, the conference brings together leading biotech and pharmaceutical companies to advance the commercialization of life-changing treatments.